Synergistic effect of gefitinib and rofecoxib in mesothelioma cells

BACKGROUND: Malignant mesothelioma (MM) is an aggressive tumor that is resistant to conventional modes of treatment with chemotherapy, surgery or radiation. Research into the molecular pathways involved in the development of MM should yield information that will guide therapeutic decisions. Epiderma...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Stoppoloni, Daniela, Canino, Claudia, Cardillo, Irene, Verdina, Alessandra, Baldi, Alfonso, Sacchi, Ada, Galati, Rossella
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2010
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2828989/
https://ncbi.nlm.nih.gov/pubmed/20122271
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1476-4598-9-27
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller